These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 14761598)

  • 1. [Expression of cytokeratins and ret in thyroid papillary carcinoma].
    Zhou WX; Xiao Y; Liu TH; Luo YF; Cao JL
    Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):530-3. PubMed ID: 14761598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation.
    Shin E; Chung WY; Yang WI; Park CS; Hong SW
    J Korean Med Sci; 2005 Feb; 20(1):98-104. PubMed ID: 15716612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
    Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
    Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.
    Baloch ZW; Abraham S; Roberts S; LiVolsi VA
    Hum Pathol; 1999 Oct; 30(10):1166-71. PubMed ID: 10534163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
    Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
    J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary carcinoma of the thyroid: a tumour still with no benign neoplastic counterpart.
    Stephenson TJ
    Histopathology; 2001 Nov; 39(5):536-8. PubMed ID: 11737313
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
    Omar E; Madhavan M; Othman NH
    Pathology; 2004 Apr; 36(2):152-9. PubMed ID: 15203751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas.
    Shin E; Hong SW; Kim SH; Yang WI
    Yonsei Med J; 2004 Apr; 45(2):306-13. PubMed ID: 15119004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters.
    Lam AK; Montone KT; Nolan KA; Livolsi VA
    Hum Pathol; 1998 Jun; 29(6):565-8. PubMed ID: 9635675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes].
    Chen Y; Zhu M; Zhou X; Lin W; Ni C; Li F; Zhang S; Gong Z
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):257-61. PubMed ID: 11953175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
    Mishra A; Agrawal V; Krishnani N; Mishra SK
    J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining and RT-PCR: different approaches to search for RET rearrangements in patients with papillary thyroid carcinoma.
    Rebelo S; Domingues R; Catarino AL; Mendonça E; Santos JR; Sobrinho L; Bugalho MJ
    Int J Oncol; 2003 Oct; 23(4):1025-32. PubMed ID: 12963982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
    Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
    Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
    Zhu XL; Zhou XY; Zhang TM; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET oncogene expression of papillary thyroid carcinoma in Korea.
    Chung KW; Chang MC; Noh DY; Oh SK; Choe KJ; Youn YK
    Surg Today; 2004; 34(6):485-92. PubMed ID: 15170542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of RET immunostaining in follicular lesions of the thyroid.
    Cerilli LA; Mills SE; Rumpel CA; Dudley TH; Moskaluk CA
    Am J Clin Pathol; 2002 Aug; 118(2):186-93. PubMed ID: 12162676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1.
    Casey MB; Lohse CM; Lloyd RV
    Endocr Pathol; 2003; 14(1):55-60. PubMed ID: 12746563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET proto-oncogene expression of papillary thyroid carcinomas in Thai patients.
    Keelawat S; Shuangshoti S; Assanasen T; Thanakit V; Ruangvejvorachai P; Poumsuk U; Wannakrairot P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S5-12. PubMed ID: 17718263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.